Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line?

Iris Lee; Serban Constantinescu; Avrum Gillespie; Abhishek Swami; Mark Birkenbach; Stephen Leech; Patricio Silva; Andreas Karachristos; John A. Daller; Nicole M. Sifontis

Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line?

Iris Lee, Serban Constantinescu, Avrum Gillespie, Abhishek Swami, Mark Birkenbach, Stephen Leech, Patricio Silva, Andreas Karachristos, John A. Daller, Nicole M. Sifontis

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	425-429
Number of pages	5
Journal	Clinical transplants
State	Published - 2009
Externally published	Yes

OpenUrl availability

Full text

Cite this

@article{9c302673168444d79fd9aa2ee75d221a,

title = "Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line?",

author = "Iris Lee and Serban Constantinescu and Avrum Gillespie and Abhishek Swami and Mark Birkenbach and Stephen Leech and Patricio Silva and Andreas Karachristos and Daller, {John A.} and Sifontis, {Nicole M.}",

year = "2009",

language = "English (US)",

pages = "425--429",

journal = "Clinical transplants",

issn = "0890-9016",

publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Bortezomib as therapy for mixed humoral and cellular rejection

T2 - should it be first line?

AU - Lee, Iris

AU - Constantinescu, Serban

AU - Gillespie, Avrum

AU - Swami, Abhishek

AU - Birkenbach, Mark

AU - Leech, Stephen

AU - Silva, Patricio

AU - Karachristos, Andreas

AU - Daller, John A.

AU - Sifontis, Nicole M.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=77954582214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954582214&partnerID=8YFLogxK

M3 - Article

C2 - 20524309

AN - SCOPUS:77954582214

SN - 0890-9016

SP - 425

EP - 429

JO - Clinical transplants

JF - Clinical transplants

ER -

Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line?

OpenUrl availability

Other files and links

Cite this